Based on the characteristics of the MTA1-derived immunosuppressive microenvironment, we can further focus on enhancing the tumor-killing effect of CD8+ T cells by interfering with the MTA1 level since it intermediates the interaction between CD8+ T cells and tumor cells. The gene discussed is CD8A; the disease is neoplasm.